findmyKOL
Clinical trialNCT01851330CompletedPhase 3Interventional

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

SponsorGilead SciencesEnrollment647Chronic Hepatitis C Virus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Birmingham, Alabama, United States

  • Facility name not stated

    La Jolla, California, United States

  • Facility name not stated

    Los Angeles, California, United States

  • Facility name not stated

    Palo Alto, California, United States

  • Facility name not stated

    Sacramento, California, United States

  • Facility name not stated

    San Diego, California, United States

  • Facility name not stated

    San Francisco, California, United States

  • Facility name not stated

    Aurora, Colorado, United States

  • Facility name not stated

    Englewood, Colorado, United States

  • Facility name not stated

    Washington D.C., District of Columbia, United States

  • Facility name not stated

    Gainesville, Florida, United States

  • Facility name not stated

    Jacksonville, Florida, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    Orlando, Florida, United States

  • Facility name not stated

    Wellington, Florida, United States

  • Facility name not stated

    Atlanta, Georgia, United States

  • Facility name not stated

    Decatur, Georgia, United States

  • Facility name not stated

    Marietta, Georgia, United States

  • Facility name not stated

    Chicago, Illinois, United States

  • Facility name not stated

    Indianapolis, Indiana, United States

  • Facility name not stated

    Bowling Green, Kentucky, United States

  • Facility name not stated

    Baton Rouge, Louisiana, United States

  • Facility name not stated

    Baltimore, Maryland, United States

  • Facility name not stated

    Lutherville, Maryland, United States

  • Facility name not stated

    Boston, Massachusetts, United States

  • Facility name not stated

    Novi, Michigan, United States

  • Facility name not stated

    Kansas City, Missouri, United States

  • Facility name not stated

    St Louis, Missouri, United States

  • Facility name not stated

    Albuquerque, New Jersey, United States

  • Facility name not stated

    Berlin, New Jersey, United States

  • Facility name not stated

    Hillsborough, New Jersey, United States

  • Facility name not stated

    Santa Fe, New Mexico, United States

  • Facility name not stated

    Binghamton, New York, United States

  • Facility name not stated

    Manhasset, New York, United States

  • Facility name not stated

    New York, New York, United States

  • Facility name not stated

    Chapel Hill, North Carolina, United States

  • Facility name not stated

    Fayetteville, North Carolina, United States

  • Facility name not stated

    Statesville, North Carolina, United States

  • Facility name not stated

    Winston-Salem, North Carolina, United States

  • Facility name not stated

    Philadelphia, Pennsylvania, United States

12 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2013
Primary completion
31 Dec 2013
Completion
31 Mar 2014
Last update posted
16 Nov 2018
Registered enrollment
647
Registry id
NCT01851330

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.